Top Markets
Coin of the day
Manzo Pharmaceuticals, Inc. Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO
株式のランク #40587
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
株価
$0.0001
最終同期: 2026-08-12
時価総額
$115.95K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Manzo Pharmaceuticals, Inc. (MNZO)

カテゴリー

Manzo Pharmaceuticals, Inc.(MNZO)の収益
Aug 2026 時点の収益 TTM: 0
Manzo Pharmaceuticals, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Manzo Pharmaceuticals, Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。